The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Vaccines for the 21st Century: A Tool for Decisionmaking
Biotechnology, 26 , 30 , 33–34 , 90 , 379 , 381–386
attenuated live viruses, 19 , 20 , 24–25 , 328–329 , 352 , 379
Epstein-Barr virus, 332–333 , 334
hepatitis B virus, 18 , 379
hepatitis C virus, 337
herpes simplex virus, 327–328
Histoplasma capsulatum 358
hybridoma, 30
monoclonal antibodies, 29–30
mycobacterium tuberculosis, 355
papillomaviruses, 339–340
risk capital, 125
Salmonella , 31–32
see also DNA; Genomes; RNA
Bordetella pertussis , 11 , 18 , 19 , 20 , 28 , 30 , 46
Borrelia burgdorferi , 7 , 44 , 54 , 88 , 91 , 100 , 143–148
Burkitt’s lymphoma, 330 , 331 , 332 , 333
C
Canada, 49 , 62 , 66 , 68 , 96 , 99
Cancer, 1 , 12 , 185 , 189 , 190 , 194 , 213–219 , 381 , 411 , 415–433
autoimmune therapy, 427–429 , 431
Epstein-Barr virus, 330–333
melanoma, 6 , 54 , 88 , 89–90 , 239–243 , 421
papillomaviruses, 338–342
Caribbean region, 343
Centers for Disease Control and Prevention, 14 , 28 , 50 , 100 , 125 , 126
Central nervous system, 67 , 399–403
herpes simplex virus, 196–200 (passim), 202 , 204 , 328
multiple sclerosis, 6 , 35 , 54 , 87 , 245–249 , 397 , 399–400
see also Neisseria meningitidis
Children, 7 , 8–9 , 45–47 , 60 , 69 , 72 , 80–82 , 91 , 99 , 100 , 101 , 111 , 130 , 377
American Academy of Pediatrics, 45 , 126
CDC recommendations, 28
chlamydia, 6 , 88 , 157
combination vaccines, 9 , 18 , 38 , 46–47 , 75 , 130
contraceptive vaccines, health effects, 76
cytomegalovirus, 6 , 90 , 167
dengue virus, 343 , 345
Epstein-Barr virus, 7 , 88 , 177 , 179 , 330–331 , 333
gonorrhea, 6 , 88
Helicobacter pylori , 181
herpes simplex virus, 6 , 88 , 196 , 203 , 329
influenza virus, 223–224
liability issues, 128–129
meningitis, 267
National Childhood Vaccine Injury Act, 20–21 , 128–129 , 258
papillomaviruses, 6 , 88 , 219 , 342
pregnant, 51
polio, 24
record-keeping, 46 , 47 , 49
respiratory syncytial virus, 88 , 279 , 280 , 281
rotavirus, 291–292
school entry immunizations, 7 , 8–9 , 20 , 49 , 90 , 130
Shigella , 295
streptococcus, group A, 299 , 363
streptococcus, group B, 6 , 93 , 310 , 311–312
Streptococcus pneumoniae 313 , 314 , 315
Vaccines for Children Program, 47 , 131
see also Infants
Children’s Vaccine Initiative, 127–128
China, 334
Chlamydia, 6 , 54 , 67 , 88 , 89–90 , 97 , 149–158 , 347–351 , 368
Cholera, see Vibrio cholerae
Clinical trials, 9 , 19 , 70 , 105 , 126 , 406 , 417 , 424 , 430–431 , 436
djuvants, 373 , 374
AIDS, 373 , 379
Bordetella pertussis , 30
